Protagenic Therapeutics (PTIX) 8-K Summary
Date of Event: October 28, 2025
Protagenic Therapeutics filed a Form 8-K detailing litigation against a recent acquisition target.
Key Event (Item 8.01)
The Company filed a Verified Complaint in the Delaware Chancery Court seeking:
- Rescission of the Share Exchange Agreement dated May 15, 2025, by which it acquired Phytanix Bio, Inc.; OR
- Alternative relief including damages and an order compelling delivery of required audited financial statements.
...This action signals a material dispute related to the Phytanix acquisi